Newsbenzinga
Stoke To Participate In Pre-NDA FDA Meeting During 2H 2026 As It Plans To Initiate Planned Rolling NDA Submission For Zorevunersen In Q1 2027
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…